Cargando…
Therapeutic Strategies for High-Dose Vasopressor-Dependent Shock
There is no consensual definition of refractory shock. The use of more than 0.5 mcg/kg/min of norepinephrine or epinephrine to maintain target blood pressure is often used in clinical trials as a threshold. Nearly 6% of critically ill patients will develop refractory shock, which accounts for 18% of...
Autores principales: | Bassi, Estevão, Park, Marcelo, Azevedo, Luciano Cesar Pontes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787628/ https://www.ncbi.nlm.nih.gov/pubmed/24151551 http://dx.doi.org/10.1155/2013/654708 |
Ejemplares similares
-
Outcome of patients with septic shock and high-dose vasopressor therapy
por: Auchet, Thomas, et al.
Publicado: (2017) -
Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock
por: Zabet, Mohadeseh Hosseini, et al.
Publicado: (2016) -
Platelet-derived exosomes from septic shock patients induce myocardial dysfunction
por: Azevedo, Luciano Cesar Pontes, et al.
Publicado: (2007) -
Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition
por: Guinot, Pierre-Grégoire, et al.
Publicado: (2021) -
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
por: Bloom, Jason E., et al.
Publicado: (2023)